arrow
E

Elaine S. Jaffe

national cancer institute
H指数:167
被引数:12.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma

一項关于romidepsin、azacitidine、dexamethasone和lenalidomide在复发或难治性T细胞淋巴瘤中的1期临床试验

2026-02-160
OAAI
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study

基因表达谱分析揭示了两种主要的ALCL类型,具有不同的可靶向生物学特征:LLMPP研究

Blood
IF23.1
2025-11-240
PRE
Follicular helper T-cell lymphomas with EBV-positive neoplastic cells: a rare scenario with diagnostic implications

滤泡辅助T细胞淋巴瘤伴EBV阳性肿瘤细胞:一种具有诊断意义的罕见情况

2025-08-260
PRE
Characteristics and outcomes of Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS)

卡波西肉瘤相关疱疹病毒(KSHV)诱导的炎症细胞因子综合征(KICS)的特征和结局

2025-08-070
OAAI
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

高级别B细胞淋巴瘤,非其他特指类型:一项LLMPP研究。

2025-07-210
OAAI
The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study

间变性大细胞淋巴瘤的表型景观支持新的分子分类: 一项LLMPP研究

2025-03-010
PRE
Refining Diagnostic Subtypes of Peripheral T-Cell Lymphoma Using a Multiparameter Approach

使用多参数方法细化外周T细胞淋巴瘤的诊断亚型

2025-02-010
PRE
Indeterminate DC histiocytosis is distinct from LCH and often associated with other hematopoietic neoplasms
2024-11-140
OAAI
Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and MYC Rearrangement- an LLMPP Study

根据EBV状态和MYC重排定义的浆细胞样淋巴瘤的生物与预后亚组——一项LLMPP研究

BLOOD
IF23.1
2024-11-050
PRE
Phase lb/2 Study of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed/Refractory and Treatment-Naive Mantle Cell Lymphoma: Preliminary Analysis of Safety, Efficacy, and Minimal Residual Disease

维奈克拉、依鲁替尼、泼尼松、奥滨尤妥珠单抗和来那度胺(ViPOR)在复发/难治性及初治套细胞淋巴瘤中的lb/2期研究:安全性、有效性和微小残留病初步分析

BLOOD
IF23.1
2024-11-050
PRE
Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma
2024-09-230
OAAI
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma
2024-06-205
OAAI